Issues with Wegovy: what's real, what's rumour, and what to do

The biggest misconception: Wegovy side effects mean the medicine isn't working

The myth that circulates most stubbornly about Wegovy is this: if you feel rough on it, something has gone wrong. In practice, the opposite is often true. Semaglutide (the active ingredient in Wegovy) slows the rate at which the stomach empties food into the small intestine. That's part of how it reduces appetite and helps with weight management. It also means your gut is adapting to a different rhythm, and that adaptation produces nausea, burping, constipation or loose stools in a large share of people who start it.

The STEP 1 trial, published in the New England Journal of Medicine, enrolled nearly 1,961 adults and found gastrointestinal events were the most frequently reported side effects, but the majority were mild to moderate and temporary. The dose escalation schedule exists precisely to give your system time to adjust: the 0.25mg starting dose isn't a therapeutic dose, it's there to reduce the shock to your gut before you move higher. Many people find that nausea peaks in the first week after a dose increase and is largely gone by week three or four. Eating smaller portions, avoiding high-fat meals around injection day, and staying well hydrated all help.

So if you're feeling queasy on your first pen, that's not a signal to stop. It's worth discussing with your prescriber (who can slow the escalation if needed) before drawing any conclusions. You can read more about stomach issues on Wegovy specifically if the GI side is your main concern.

The issues that do warrant medical attention

Not every Wegovy problem is something to wait out, and being clear about which symptoms need prompt attention matters. In January 2026, the MHRA published a Drug Safety Update for GLP-1 medicines (the class that includes semaglutide) highlighting acute pancreatitis as a known but infrequent risk. The signal to act on is severe stomach pain that spreads towards the back, particularly if it's accompanied by vomiting and doesn't ease. That warrants same-day medical help, not a wait-and-see approach.

Other symptoms worth flagging to a doctor rather than managing at home: signs of a serious allergic reaction (swelling of the face or throat, difficulty breathing), significant dehydration following prolonged vomiting or diarrhoea, or persistent symptoms that aren't improving weeks into a dose. Gallbladder problems (pain in the upper right abdomen, especially after eating) are another reported association with GLP-1 medicines, and while uncommon, they shouldn't be dismissed as routine reflux.

The semaglutide information page covers the full side-effect profile in more detail, or you can read the NHS semaglutide medicines page for patient-level guidance on what to watch for and when to seek help. Suspected side effects can also be reported directly at the MHRA's Yellow Card scheme (yellowcard.mhra.gov.uk), something a lot of patients don't know they're entitled to do.

The Wegovy issues people don't always connect to the medicine

Some of the concerns our prescribers hear most often aren't the classic GI complaints, they're subtler changes that patients aren't sure to attribute to Wegovy at all. Sleep disruption, for instance, has been reported anecdotally by a meaningful number of people on semaglutide. There's a plausible mechanism: nausea or discomfort lying down, combined with changed eating patterns and possible effects on overnight blood glucose, can all affect sleep quality. It doesn't happen to everyone, but if you've noticed it, you're not imagining it. There's a dedicated page on Wegovy and sleep issues if that's relevant to you.

Changes to menstrual cycles are another thing people notice but don't always connect to treatment. Significant weight loss itself can affect hormonal rhythms, and semaglutide's effect on body composition and gut hormones may play a role too. The picture is still emerging scientifically, but it's worth flagging to your prescriber. Similarly, some people have raised questions about dental and oral health changes on GLP-1 treatment, often linked to reduced saliva production, dietary changes, or increased stomach acid from reflux. The Wegovy and teeth page covers what's known there.

The detail that sometimes gets lost in the side-effect conversation is that these medicines are affecting your whole system, not just your appetite. That's worth knowing before you start, not after. For a fuller picture of what semaglutide is actually doing in the body, the dedicated explainer is a good read.

When the issue is cost, not clinical, and what that means for safety

A separate category of Wegovy problems isn't medical at all: it's financial. Wegovy is a prescription-only medicine, and the cost of private treatment is real. Some people respond to that by looking for cheaper sources online or via social media. That's understandable, but it carries genuine risks. The MHRA has seized large quantities of fake GLP-1 pens sold without a prescription, and some counterfeit products have been found to contain the wrong active ingredient entirely.

If cost is the barrier, it's worth understanding what a legitimate private price actually includes. Our Wegovy prices page explains how private treatment is structured and what to look for in a quote. A prescriber reviewing your case, a pharmacy you can verify on the GPhC register, and clinical support if something goes wrong aren't extras, they're the baseline. A Friday afternoon online order that arrives in a jiffy bag with no clinical contact isn't a bargain. It's a different product.

If you'd like to explore whether Wegovy is clinically suitable for you, the straightforward first step is to check your eligibility with our prescribers, there's no obligation, and the consultation is free.